CompletedNot Applicable

Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment

United States209 participantsStarted 2019-01-18

Plain-language summary

This study will help the researchers learn more about factors that affect the decisions about fertility preservation and family building made by young women with breast cancer.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Breast cancer, Stage 0-III * Female * 18-45 years of age at time of diagnosis * Patients that completed their primary breast cancer treatment (surgery, chemotherapy, radiation therapy). Patients can still be on endocrine therapy, trastuzumab and/or pertuzumab therapy. * Received education and counseling by MSK Fertility Nurse Specialist before beginning cancer treatment from 2009 through 2018 Exclusion Criteria: * Unable to read English

What they're measuring

Patient-reported outcome questionnaire - Fertility Preservation Questionnaire

Timeframe: 1 year

Trial details

NCT IDNCT03817814

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-11

View on ClinicalTrials.gov More Fertility Preservation trials